How do analysts rate TITAN MEDICAL INC (TMD.CA)?
The consensus rating for TITAN MEDICAL INC (TMD.CA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
TITAN MEDICAL INC (TMD.CA) Forecast, Price Target & Analyst Ratings
TSX:TMD • CA88830X8199
Current stock price
0.8 CAD
-0.04 (-4.76%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TITAN MEDICAL INC (TMD.CA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$0.00
Upside
-100.00%
From current price of CA$0.80 to mean target of CA$0.00, Based on 5 analyst forecasts
Low
CA$0.00
Median
CA$0.00
High
CA$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
TMD.CA was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about TMD.CA.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed TMD.CA. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-03-25 | Oppenheimer Holdings | Initiate | Market Perform |
| 2022-03-25 | STA Research | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 20.093M 0.46% | -100.00% | 17.632M | |
| EBITDA YoY % growth | -30.288M -782.16% | -43.912M -44.98% | 9.135M 120.80% | |
| EBIT YoY % growth | -30.987M -837.79% | -44.771M -44.48% | 8.949M 119.99% | |
| Operating Margin | -154.22% | N/A | 50.75% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A